Your browser doesn't support javascript.
loading
Permeability of the blood-brain barrier predicts no evidence of disease activity at 2 years after natalizumab or fingolimod treatment in relapsing-remitting multiple sclerosis.
Cramer, Stig P; Simonsen, Helle J; Varatharaj, Aravinthan; Galea, Ian; Frederiksen, Jette L; Larsson, Henrik B W.
Afiliação
  • Cramer SP; Functional Imaging Unit, Department of Clinical Physiology, Nuclear Medicine, and PET, Rigshospitalet, Copenhagen, Denmark.
  • Simonsen HJ; Functional Imaging Unit, Department of Clinical Physiology, Nuclear Medicine, and PET, Rigshospitalet, Copenhagen, Denmark.
  • Varatharaj A; Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Galea I; Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Frederiksen JL; Department of Neurology, Rigshospitalet, Glostrup, Denmark.
  • Larsson HBW; Institute of Clinical Medicine, Faculty of Health and Medical Science, Copenhagen University, Copenhagen, Denmark.
Ann Neurol ; 83(5): 902-914, 2018 05.
Article em En | MEDLINE | ID: mdl-29604233
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Permeabilidade / Barreira Hematoencefálica / Esclerose Múltipla Recidivante-Remitente / Cloridrato de Fingolimode / Natalizumab Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Permeabilidade / Barreira Hematoencefálica / Esclerose Múltipla Recidivante-Remitente / Cloridrato de Fingolimode / Natalizumab Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article